Article Information
History
- April 13, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 13, 2022 - 18:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Youwei Xu1,8,
- Canrong Wu1,8,
- Xiaodan Cao2,8,
- Chunyin Gu2,8,
- Heng Liu1,8,
- Mengting Jiang3,1,
- Xiaoxi Wang1,
- Qingning Yuan1,4,
- Kai Wu1,4,
- Jia Liu2,
- Xianqing He2,
- Deyi Wang2,
- Xueping Wang2,
- Su-Jun Deng2,*,
- H. Eric Xu1,5,6,* and
- Wanchao Yin1,5,7,*
- 1The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- 2Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai 201203, China
- 3School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China
- 4The Shanghai Advanced Electron Microscope Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- 5University of Chinese Academy of Sciences, Beijing 100049, China
- 6School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
- 7Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Guangdong 528400, China
- ↵*Correspondence should be addressed to Su-Jun Deng (dengsujun{at}jemincare.com) or H. Eric Xu (eric.xu{at}simm.ac.cn) or Wanchao Yin (wcyin{at}simm.ac.cn)
↵8 These authors contributed equally: Youwei Xu, Canrong Wu, Xiaodan Cao, Chunyin Gu, Heng Liu